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Abstract
Objective—Impaired angiogenesis is a known consequence of metabolic syndrome (MetS),
however, the mechanism is not fully understood. Recent studies have shown that the Notch
signaling pathway is an integral component of cardiac angiogenesis. We tested in a clinically
relevant swine model the effects of MetS on Notch and apoptosis signaling in chronically
ischemic myocardium.
Methods—Ossabaw swine were fed either a regular diet (CTL, n=8) or a high-cholesterol diet
(MetS, n=8) to induce MetS. An ameroid constrictor was placed to induce chronic myocardial
ischemia. Eleven weeks later, animals underwent cardiac harvest of the ischemic myocardium.
Results—There was down-regulation of pro-angiogenesis proteins Notch2, Notch4, Jagged2,
Ang1 and ENOS in the MetS group compared to CTL. There was also up-regulation of pro-
apoptosis protein Caspase8, and down-regulation of anti-angiogenesis protein pFOX03, and pro-
survival proteins pP38 and HSP90 in the MetS group. Cell death was increased in the MetS group
compared to CTL. Both CTL and MetS groups had similar arteriolar count and capillary density,
and Notch3 and Jagged1 were both similarly concentrated in the smooth muscle wall in both
groups.
Conclusions—MetS in chronic myocardial ischemia significantly impairs Notch signaling by
down regulating Notch receptors, ligands and pro-angiogenesis proteins. MetS also increases
apoptosis signaling, decreases survival signaling and increases cell death in chronically ischemic
myocardium. Although short-term angiogenesis appears unaffected in this model of early MetS,
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the molecular signals for angiogenesis are impaired, thus suggesting that inhibition of Notch
signaling may underlie decreased angiogenesis in later stages of MetS.
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coronary disease; ischemia; molecular biology
Introduction
Metabolic syndrome is a cluster of metabolic derangements including obesity, insulin
resistance, glucose intolerance, dyslipidemia and hypertension. Metabolic syndrome
substantially increases the risk of cardiovascular disease and mortality.1, 2 Despite
advancements in surgical technique and percutaneous interventions, patients with
hypertension, hyperlipidemia and diabetes have a significantly higher mortality after
angioplasty, coronary stenting and coronary artery bypass grafting.3 Promising results from
animal studies in therapeutic revascularization with growth factor, gene or cell therapy has
been met with disappointing results in humans with minimal clinical improvements in
myocardial angiogenesis.4 Not surprisingly, young healthy animals with chronic myocardial
ischemia are better able to adapt to ischemic insult, whereas older patients with multiple
comorbidities, including MetS, have limited myocardial adaptability to ischemia. The
discordant results between positive animal studies and negative clinical results highlights the
need to understand the effects of MetS on molecular angiogenic signaling pathways using a
clinically relevant animal model.
Ossabaw miniswine are a breed of feral pigs that were isolated on Ossabaw Island off the
coast of Georgia almost 500 years ago by Spanish explorers. This pig breed has been
identified as an excellent model for metabolic syndrome due to its “thrifty genotype”, which
allowed these pigs to adapt to the harsh island conditions by storing large amounts of fat
during the feasting period.5 When sedentary and fed a high-fat, high-calorie, atherogenic
diet, these animals develop profound obesity and all the hallmark features of MetS and are a
useful model to sudy MetS and coronary artery disease.5-7
We recently demonstrated that animals with chronic myocardial ischemia and perivascular
VEGF had significantly improved neovascularization and Notch receptor and ligand
expression.8 The Notch signaling pathway is an evolutionarily conserved pathway that is
important for many processes including cell fate determination differentiation, proliferation,
apoptosis, and regeneration.9 Studies have shown that postnatal Notch signaling is critical
for angiogenesis.10, 11 There is growing interest in the clinical utility of Notch modulators to
suppress angiogenesis in tumors, and promote angiogenesis in ischemic myocardium.12
While research in the role of Notch signaling in developmental biology is longstanding, the
role of Notch in mature myocardium in response to ischemia and metabolic syndrome is
largely unknown. The purpose of this study is to examine the effects of metabolic syndrome
on Notch signaling in response to chronic myocardial ischemia in the clinically relevant
Ossabaw model of early MetS.
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Sixteen intact male Ossabaw miniswine (Purdue Ossabaw Facility, Indiana University,
Indianapolis, IN) were split into two groups according to diet at 6 weeks of age. The control
group was fed 500g/day of regular chow (CTL, n=8). The high-cholesterol animals were fed
500g/day of high-cholesterol chow consisting of (by weight) 4% cholesterol, 17.2% coconut
oil, 2.3% corn oil, 1.5% sodium cholate, and 75% regular chow (Sinclair Research,
Columbia, MO) (MetS, n=8). After 9 weeks of diet initiation, all animals underwent surgical
placement of an ameroid constrictor to induce chronic myocardial ischemia (see surgical
interventions). Postoperatively, all animals continued on their respective diets. Eleven weeks
after ameroid constrictor placement, all animals underwent euthanasia and cardiac tissue
harvest. All animals were observed to ensure complete consumption of food, had unlimited
access to water, and were housed in a warm non-stressful environment for the duration of
the experiment.
SURGICAL INTERVENTIONS
Anesthesia—Anesthesia was induced with an intramuscular injection of telazol (4.4 mg/
kg). Animals were endotracheally intubated, mechanically ventilated at 12 - 20 breaths per
minute, and general anesthesia was maintained with a gas mixture of oxygen at 1.5 - 2
liters/min and 0.75-3.0% isoflurane.
Ameroid Constrictor Placement—Animals were given a single dose of intravenous
enrofloxacin (5 mg/kg) for antibiotic prophylaxis and general anesthesia was induced and
maintained. Animals were prepped and draped in the usual sterile fashion. The heart was
exposed through a left mini-thoracotomy through the fourth intercostal space and
pericardiotomy. The left atrial appendage was retracted and the left circumflex artery was
dissected at the take off of the left main coronary artery. A titanium ameroid constrictor
(1.75-2.25 mm internal diameter) ameroid constrictor was placed around the proximal left
circumflex artery, just after its take off from the left main coronary artery. (Research
Instruments SW, Escondito, CA). The pericardium was loosely re-approximated with
interrupted 4-0 neurolon sutures (Ethicon, Somerville, NJ) followed by a layered closure of
the surgical incision. Post-operative pain was controlled with a single dose of intramuscular
buprenorphine (0.03 mg/kg) and 72 hour fentanyl patch (4 g/kg). All animals received 325
mg of aspirin daily starting 1 day pre-operatively and continuing for a total of 5 days for
prophylaxis against thrombo-embolic events. All animals continued perioperative
antibiotics: enrofloxacin 68 mg orally daily for 5 days.
Cardiac Harvest—Under general anesthesia, the heart was exposed via a median
sternotomy and animals were euthanized by exsanguinations. Cardiac tissue from the
ischemic territory in the left circumflex artery distribution was collected for further analysis.
The Institutional Animal Care and Use Committee of the Rhode Island Hospital approved all
experiments. Animals were cared for in compliance with the “Principles of Laboratory
Animal Care” formulated by the National Society for Medical Research and the “Guide for
the Care and Use of Laboratory Animals” (NIH publication no. 5377-3 1996).
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IMMUNOHISTOCHEMICAL STAINING FOR ANGIOGENESIS
Frozen myocardium was sectioned (10-m-thickness) and fixed in 10% formalin for 10
minutes. Sections were blocked with 1% bovine serum albumin in phosphate buffered saline
for 1 hour at room temperature and incubated with antibodies against porcine endothelial
marker CD-31 (R&D Systems, Minneapolis, MN) and smooth muscle actin (Sigma Aldrich,
St. Louis, MO), followed by the appropriate alexa-fluor conjugated antibody (Jackson
ImmunoResearch, West Grove, PA) for 45 minutes. Slides were then mounted with DAPI-
containing medium Vectashield (Vector Laboratories, Burlingame, CA). Images were
captured at X20 magnification with a Nikon E800 Eclipse microscope (Nikon, Tokyo,
Japan) at the same exposure in three random fields. Capillaries were defined as structures
between 5-25 m2 in cross-sectional area and arterioles were defined by co-localization of
smooth muscle actin (red) and CD-31 (green) staining. Arteriolar density and capillary
density was measured using Image J software (National Institutes of Health, Bethesda, MD).
The percent capillary and arteriolar density for each animal was averaged from the three
randomly selected myocardial tissue sections.
PROTEIN EXPRESSION
Forty micrograms of the Radio-Immunoprecipitation Assay (Boston BioProducts, Ashland,
MA) soluble fraction of myocardial lysates were fractionated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis 3-8% Tris-acetate gel (NuPage Novex Mini Gel,
Invitrogen, Carlsbad, CA) for molecular weight targets >100 kilodaltons and 4-12% Bis-Tris
gels for molecular weight targets <100 kilodaltons (NuPage Novex Mini Gel, Invitrogen).
The protein was then transferred to polyvinylidene difluoride membranes (Millipore,
Billerica, MA) and incubated overnight at 4 °C with primary antibodies at dilutions
recommended by the manufacturer against Notch1, Notch2, Notch3, Notch4, Jagged1,
Jagged2, Vascular Endothelial Growth Factor Receptor 2 (VEGFR2), Vascular Endothelial
Cadherin (VECadherin), Endothelial Nitric Oxide Synthase (ENOS), Transforming Growth
Factor β (TGFβ), Caspase8, Caspase3, Cleaved Caspase3, Forkhead Box Transcription
Factor 03 (Fox03), phosphorylated Fox03, Apoptosis Inducing Factor (AIF), P38,
phosphorylated P38 (pP38), Heat Shock Protein 90 (HSP90) (all from Cell Signaling,
Danvers, MA) and VEGFR3 and angiopoietin 1 (Ang1) (both from Abcam, Cambridge,
MA). Membranes were incubated with the appropriate horseradish peroxidase-linked
secondary antibody for one hour at room temperature (Jackson ImmunoResearch, West
Grove, PA). Immune complexes were visualized with enhanced chemiluminescense and
images were captured with a digital camera system (G-Box, Syngene, Cambridge, England).
Band densitometry was quantified as arbitrary light units using Image-J software. All
membranes were probed with GAPDH (Cell Signaling) to correct for loading error.
IMMUNOHISTOCHEMICAL STAINING FOR NOTCH SIGNALING PROTEINS
Frozen myocardium was sectioned (10-m-thickness) and fixed in 10% formalin for 10
minutes. Sections were blocked with 1% bovine serum albumin in phosphate buffered saline
for 1 hour at room temperature and incubated with antibodies against Notch2, Notch3,
Notch4 or Jagged1 (Cell Signaling) and smooth muscle actin (SMA, Sigma Aldrich) co-
staining, followed by the appropriate alexa-fluor conjugated antibody (Jackson
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ImmunoResearch) for 45 minutes. Slides were then mounted with Vectashield. Images were
captured at X20 magnification with a Nikon E800 Eclipse microscope at the same exposure
in three random fields. Immunofluorescence mean intensity was measured using Image J
software. The immunofluorescence mean intensity for each animal was averaged from the
three randomly selected myocardial tissue sections.
TUNEL STAINING
Frozen myocardium from the ischemic territory was sectioned (10-m-thickness). Apoptotic
cells were identified using the commercially available ApopTag detection kit (Millipore,
Billerica, MA) according to the manufacturer’s instructions. Images were captured at X20
magnification using Aperio ScanScope technology (Vista, CA) in three random fields from
each animal. The percentage of TUNEL-positive cardiomyocytes per high powered field
was measured using Image J software. The percent cell death per high powered field for
each animal was averaged from the three randomly selected myocardial tissue sections.
DATA ANALYSIS
All results are reported as mean ± standard error of the mean. A Student’s T-test was used to
compare the means with GraphPad Prism 5.0 Software (GraphPad Software Inc., San Diego,
CA). Differences with a p value <0.05 were considered statistically significant. Protein
expression is reported as fold change compared to CTL.
Results
Animal Model
All animals included in the analysis survived the entire experiment. One animal in the CTL
group died on post-operative day 8, and 1 animal in the MetS group died on post-operative
day 2. Necropsy was unremarkable, and it was assumed that both animals died of an acute
ventricular arrhythmia. The animals that did not survive to completion of the experiment
were excluded from analysis and replaced with new animals. We previously reported that
there was no difference in myocardial perfusion or contractility.13 We also reported that the
animals in the MetS group developed key components of metabolic syndrome including
obesity (BMI 31.9 vs 35.1 in CTL vs MetS p<0.01), hypertension (MAP 85 mmHg vs 112
mmHg in CTL and MetS respectively p=0.02), dyslipidemia (67.9 mg/dL vs 343 mg/dL
total cholesterol in CTL and MetS respectively p<0.01) and glucose intolerance in response
to dextrose infusion (44, 149, 82 mg/dL blood glucose in CTL group vs 60, 214, 130 mg/dL
in the MetS group at 0 min, 30 min, 60 min, respectively, after dextrose infusion; p<0.01).13
Vessel Density in Chronically Ischemic Myocardium
There was no difference in capillary density in the chronically ischemic myocardium as
measured by immunohistochemical staining for CD31 (9.53±0.72 and 10.78±0.74 percent
area/high power field CTL and MetS respectively p=0.28). Also, there was no difference in
arteriolar count as measured by immunohistochemical co-staining of CD31 and smooth
muscle actin (22.91±1.18 and 23.73±0.93 count/high power field CTL and MetS
respectively p=0.59) (Figure 1).
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Angiogenesis Protein Expression in Chronically Ischemic Myocardium
We analyzed the myocardial lysates of the chronically ischemic myocardium for expression
of all 4 mammalian Notch receptors (1-3) and 2 Notch ligands (Jagged 1 and 2). In the
METS group, there was a decrease in expression of Notch2, Notch4, and Jagged2 compared
to CTL. There was also decreased expression of pro-angiogenesis proteins Ang1 and ENOS
in the MetS group compared to CTL. There was no difference in the expression of Notch1,
Notch3, Jagged 1, VEGFR1, VEGFR2, and TGFβ in the CTL and MetS groups (Table 1).
Notch Receptor and Ligand Staining in Chronically Ischemic Myocardium
We performed immunohistochemical staining of transmural sections of the ischemic
myocardium to determine the histologic location of the Notch2, Notch3 and Notch4
receptors by co-staining with smooth muscle actin. Smooth muscle actin stains vascular
smooth muscle, which is located in the wall of arteries and arterioles. Notch receptors
Notch2, Notch3, and Notch4, and Notch ligand Jagged1 (green) were highly concentrated in
the smooth muscle wall and co-localize with smooth muscle actin (red) (Figure 2 and Figure
3). Although there was no difference in overall Notch3 intensity in the CTL and MetS
groups, there was a significant decrease in Notch2 and Notch4 intensity in the MetS group
compared to CTL. There was a trend toward decreased Jagged1 immunoflurecence in the
MetS group compared to CTL, but it did not reach statistical significance.
Apoptosis and Survival Protein Expression in Chronically Ischemic Myocardium
We analyzed myocardial lysates of the chronically ischemic myocardium for the expression
of apoptosis and survival signaling proteins. We found that in the MetS group, there was up-
regulation of pro-apoptosis protein Caspase8 and down-regulation of the inhibited form of
pro-apoptosis protein Fox03, pFox03 compared to CTL. There was also significant down-
regulation of pro-survival proteins pP38 and HSP90 in the MetS group compared to CTL.
There was also increased expression of pro-apoptosis proteins Cleaved Caspase3 and AIF in
the MetS group but it did not reach statistical significance (p=0.06 and 0.09 respectively)
compared to CTL (Table 2). There was no difference in the expression of pro-apoptosis
proteins Caspase3, Fox03 or pro-survival protein P38.
TUNEL Staining in Chronically Ischemic Myocardium
We sampled the chronically ischemic myocardium and performed TUNEL staining to
quantify cell death in the CTL and MetS group. We found that there was a significant
increase in cardiomyocyte cell death in the MetS group compared to CTL (2.73±0.36 vs
1.71±0.34 p=0.05 respectively) (Figure 4).
Discussion
Coronary collateralization in response to chronic myocardial ischemia is an important
endogenous mechanism to preserve myocardial function, limit infarct size, and improve long
term survival. It is therefore critical to understand the molecular basis for how MetS inhibits
coronary collateralization and angiogenesis. In this clinically relevant swine model of
chronic myocardial ischemia, we found that early MetS attenuated Notch, angiogenesis, and
survival signaling, and up-regulated apoptosis signaling in chronically ischemic
Elmadhun et al. Page 6













myocardium. Previously, we demonstrated that feeding Ossabaw swine a high-fat, high-
calorie, atherogenic diet resulted in all of the hallmark components of MetS including
obesity, insulin resistance, glucose intolerance, elevated blood pressure and
hyperlipidemia.13, 14
The Notch signaling pathway is a short-range communication system between two
physically adjacent cells, so called juxtacrine signaling. In mammals, there are 4 Notch
receptors: Notch 1-4, and 5 receptors: Delta Like (DLL)1,3,4 and Jagged 1 and 2. The
vascular endothelium only expresses receptors: Notch1, Notch2, Notch4, and ligands
Jagged1, Jagged 2, DLL1 and DLL4.12 Notch3 is predominantly expressed in the adult
arterial smooth muscle wall.15 Notch signaling is an integral part of both angiogenesis and
vasculogenesis, and is required for arterial and venous blood vessel differentiation.16 The
Notch pathway also maintains endothelial homeostasis by 1) modulating new blood vessel
sprouting via DLL4/Notch1, 2) Protecting endothelial cells from TNFα mediated apoptosis
via Notch4, and 3) regulating bone marrow endothelial progenitor cell proliferation,
apoptosis and migration to ischemic tissue via Notch1.12
The Notch pathway has been proposed as a possible target for therapeutic angiogenesis and
cardioprotection, however studies in a large animal model with clinically relevant
comorbidities, such as MetS, are lacking.12 In the present study, we demonstrate that MetS
has an inhibitory effect on Notch signaling. We found that Notch receptors Notch2, Notch3,
and Notch4, and Notch ligand Jagged1 were primarily concentrated in the vascular smooth
muscle wall, and co-localized with smooth muscle actin. This was an expected result given
that Notch3 is expressed in vascular smooth muscle cells. There was also decreased Notch2
and Notch2 staining, and a trend towards decreased Jagged1 tissue staining in the MetS
group compared to the control, suggesting that there is decreased Notch signaling in the
vascular smooth muscle wall in animals with MetS. Jagged1 has been identified as an
important Notch target during arterial wall assembly with Jagged1 inhibition resulting in
arterial defects and impaired vascular smooth muscle differentiation.17 Our results suggest
that perhaps MetS inhibits Notch signaling angiogenic response to chronic myocardial
ischemia. We also reported that there was down-regulation of pro-angiogenic proteins eNOS
and Ang1. Previous studies have demonstrated a direct link between Notch signaling and
eNOS activity.18, 19 Notch activation activates eNOS, which induces NO synthesis. In an
animal model of hindlimb ischemia, Notch inhibition in endothelial cells reduced
reperfusion and NO generation.18 Ang1 is an angiogenic factor that also activates the pro-
survival signaling pathway and initiates stem cell homing in the setting of myocardial
ischemia.20 In a porcine model of myocardial infarction, co-expression of VEGF and Ang1
was shown to increase angiogenesis, myocardial perfusion, and cardiomyocyte proliferation
in ischemic myocardium.21 In the current study, MetS had an inhibitory effect on the normal
angiogeneic response to ischemia by down-regulating eNOS and Ang1.
It is somewhat surprising that in this model of early MetS in Ossabaw swine we did not
observe a reduction in collateral dependent myocardial perfusion, as we have reported using
other strains of pigs.22, 23 This may be specific to the Ossabaw pigs, and in part as a result of
increased vascular relaxation observed using these pigs in early stage MetS.13 Perhaps the
increased microvascular relaxation may be due to up-regulation of the PPAR pathway, and it
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may also be related to the “thrifty genotype”, which enabled this pig breed to survive in the
feast/famine ecology on Ossabaw Island despite their predilection to obesity and coronary
artery disease. It may also be the case that this transient improvement in microvessel
reactivity that we previously reported also occurs in humans in early metabolic syndrome.
Later stage MetS in Ossasbaw swine, in contrast, is associated with decreased endothelium-
dependent relaxation and coronary flow reserve, thus indicating the progression of MetS
severity.6, 24-26 Given the decreased expression of Notch and angiogenesis signaling
proteins, one would expect that there would also be decreased vessel density. In this study
however, we did not find any difference in arteriolar or capillary density in the MetS group
compared to CTL. This finding may be due to the fact at these animals were supplemented
with a high fat diet for a relatively short period of time and developed early-stage MetS.
Importantly, molecular changes in angiogenesis protein expression precede histologic
changes and reductions in vessel count. If the animals were fed the high-fat diet for a longer
period of time, and had long-standing chronic MetS, the molecular down-regulation of
Notch and angiogenesis signaling would manifest in a histologically visible reduction in
angiogenesis. Indeed, Trask et al. reported decreased capillary density in Ossabaw pigs that
were older and had MetS for a longer duration.24
In addition to its pro-angiogenic properties, Notch signaling has also been found to modulate
apoptosis and survival signaling. In cell culture, pro-apoptotic TNFα administration down-
regulated Notch4 activity.27 Notch4 also increases expression of Bcl2, thereby protecting
endothelial cells from lipopolysaccharide-triggered apoptosis.28 Notch1 signaling in rat
cardiomyocytes reduces apoptosis in ischemic preconditioning by up-regulating Bcl2 and
down-regulating Bax.29 Thus, Notch signaling could be used to promote endothelial
generation and angiogenesis, and inhibit endothelial and cardiomyocyte apoptosis. Studies
in oncologic biology have shown that Notch signaling inhibits apoptosis through the AKT
pathway in neoplastic tissues.30, 31 In this study, we examined the effect of metabolic
syndrome on apoptosis-survival signaling in ischemic myocardium. There was a significant
decrease in pro-survival proteins pP38 and HSP90, a decrease in the inhibited form of pro-
apoptosis protein pFox03, and up-regulation of pro-apoptosis protein Caspase 8 in the MetS
group. There was also a trend towards increased expression of pro-apoptosis proteins AIF
and cleaved Caspase3 in the MetS group. The increase in pro-apoptosis protein expression
and decrease in expression of survival proteins in the MetS group was supported by TUNEL
staining, which demonstrated that there was increased cell death in the MetS group
compared to CTL. These results suggest that metabolic syndrome promotes apoptosis
signaling and increases cell death in the setting of chronic myocardial ischemia. Although
we previously reported that there was no difference in cardiac function, perhaps long-term
MetS-mediated cell death may result in decreased contractility and reduced adaptability to
myocardial ischemia.8 Our finding of decreased Notch signaling in this early stage MetS is
consistent with these molecular signals being causally related to decreased angiogenesis in
later stage MetS.24
Metabolic syndrome poses a significant public health dilemma and its prevalence is
increasing with no signs of slowing.32 Notch signaling has been established as an integral
component of angiogenesis and cell survival in the postnatal heart. Elucidating this complex
signaling network may assist in identifying possible Notch targets and its applicability and
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efficacy in human pathology. We provide evidence that MetS inhibits Notch signaling and
promotes cell death in chronically ischemic myocardium, which may be one way that MetS
negatively impacts overall cardiac health and increases risk for developing cardiovascular
disease.
Study Limitations
There are several limitations in the presentation and analysis of this study. Although the
animals in this study had early MetS, the known vascular consequences of MetS were not
demonstrated in the chronically ischemic myocardium, namely there was no difference in
vessel count or in microvessel relaxation. In future studies, it would be helpful to repeat the
study with multiple harvest points to establish a time course for the molecular and histologic
changes in angiogenesis in the setting of ischemia and early and established MetS.
Furthermore, although we found differences in Notch expression in this animal model of
early metabolic syndrome and chronic ischemia, causality with angiogenesis has not been
clearly established. Future studies with directed up-regulation of Notch receptor or ligands
are warranted to further elucidate the relationship between Notch signaling, metabolic
syndrome and chronic myocardial ischemia.
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Vessel Density in Chronically Ischemic Myocardium. Arrows in left panel indicate
capillaries. Arrows in right panel indicate arterioles. CTL: Ossabaw Control. MetS:
Ossabaw atherogenic diet.
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Notch Receptor and Ligand Staining in Chronically Ischemic Myocardium. Notch receptor 3
(Notch3) in green in the top panel. Smooth muscle actin (SMA) in red. Notch ligand
Jagged1 in green in the bottom panel. CTL: Ossabaw Control. MetS: Ossabaw atherogenic
diet.
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Notch Receptor Staining in Chronically Ischemic Myocardium. Notch receptor 2 (Notch2)
in green in the top panel and Notch receptor 4 (Notch4) in green in the bottom panel.
Smooth muscle actin (SMA) in red. CTL: Ossabaw Control. MetS: Ossabaw atherogenic
diet.
Elmadhun et al. Page 14














TUNEL Staining in Chronically Ischemic Myocardium. Brown spots (arrow) in nuclei
indicates cell death. CTL: Control. MetS: Ossabaw atherogenic diet.
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Table 1
Angiogenesis Protein Expression in Chronically Ischemic Myocardium
CTL MetS p Value
Notch1 1.0±0.132 0.81±0.053 0.20
Notch2 1.0±0.105 0.64±0.096 0.03
Notch3 1.0±0.076 1.11±0.088 0.38
Notch4 1.0±0.128 0.66±0.050 0.02
Jagged1 1.0±0.143 1.17±0.151 0.43
Jagged2 1.0±0.050 0.79±0.083 0.05
VEGFR2 1.0±0.082 1.12±0.127 0.43
VEGFR3 1.0±0.100 1.05±0.107 0.76
VE Cadherin 1.0±0.052 0.82±0.113 0.18
Ang1 1.0±0.070 0.72±0.045 0.01
ENOS 1.0±0.038 0.51±0.126 0.003
TGFβ 1.0±0.037 0.98±0.070 0.77
CTL: Control. MetS: Ossabaw atherogenic diet.
Values reported as fold change ± standard error of the mean compared to CTL.
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Table 2
Apoptosis and Survival Protein Expression in Chronically Ischemic Myocardium
CTL MetS p Value
Caspase8 1.0±0.051 1.19±0.051 0.02
Caspase3 1.0±0.065 1.04±0.093 0.72
Cleaved Caspase3 1.0±0.162 1.55±0.210 0.06
Fox03 1.0±0.025 0.95±0.033 0.27
pFox03 (Ser253) 1.0±0.039 0.84±0.040 0.01
AIF 1.0±0.108 1.32±0.136 0.09
P38 1.0±0.028 1.03±0.053 0.61
pP38 (Thr180/Tyr182) 1.0±0.052 0.80±0.029 0.01
HSP90 1.0±0.038 0.85±0.052 0.04
CTL: Control. MetS: Ossabaw atherogenic diet.
Values reported as fold change ± standard error of the mean compared to CTL.
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